Results 131 to 140 of about 24,588 (279)

Real‐World Treatment Patterns in AERD: An Analysis of ATAD, Biologics, and Combination Therapy

open access: yesInternational Forum of Allergy &Rhinology, Volume 16, Issue 1, Page 99-101, January 2026.
Key Points Contemporary aspirin exacerbated respiratory disorder (AERD) therapy commonly includes aspirin desensitization (55%) and biologics (48%). Aspirin desensitization therapy has higher discontinuation rates than biologics. Patients receiving biologics are younger, and ∼25% of the patients switch to other agents.
Nitish Kumar   +5 more
wiley   +1 more source

Omalizumab in the management of patients with allergic (IgE-mediated) asthma

open access: yesJournal of Asthma and Allergy, 2009
Thomas SandströmDepartment of Respiratory Medicine and Allergy, University Hospital, Umeå, SwedenAbstract: Immunoglobulin E (IgE) is central to the pathophysiology of allergic asthma.
Thomas Sandström
doaj  

Physical Activity as a New Tool to Evaluate the Response to Omalizumab and Mepolizumab in Severe Asthmatic Patients: A Pilot Study [PDF]

open access: gold, 2020
Giovanna Elisiana Carpagnano   +10 more
openalex   +1 more source

T Cell/Mast Cell Crosstalk in the Skin of Patients Suffering From Immune‐Mediated Diseases, Focusing on Chronic Spontaneous Urticaria

open access: yesClinical and Translational Allergy, Volume 16, Issue 1, January 2026.
ABSTRACT The crosstalk between immune cells in skin lesions of numerous immune‐mediated diseases such as atopic dermatitis, psoriasis and other T cell mediated is fundamental for understanding the pathogenesis and treating these diseases. The mechanisms by which most activated immune cells such as T cells, mast cells, and neutrophils are shifted from ...
Elias Toubi   +2 more
wiley   +1 more source

A severe case of lipoatrophy due to human insulin and insulin analogs in a patient with diabetes: is an immunological mechanism involved? [PDF]

open access: yes, 2011
The precipitin technique has been used in insulin resistance and immunity studies since the 1940s [7]. In the case described, the technique proved, once again, to be a valid method for choosing the most appropriate insulin. However, whether or not an
Cabrera-Freitag, P. (P.)   +5 more
core  

Bullous Wells’ syndrome successfully treated with omalizumab

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Giulia Ciccarese   +7 more
wiley   +1 more source

Serum Haptoglobin as a Predictor of Treatment Response in Patients With Chronic Spontaneous Urticaria

open access: yesClinical and Translational Allergy, Volume 16, Issue 1, January 2026.
ABSTRACT Background Chronic spontaneous urticaria (CSU) is a mast cell‐driven disease associated with systemic inflammation and altered immune responses. Haptoglobin (HP), an acute‐phase glycoprotein, exhibits antioxidative and immunomodulatory properties, while zonulin, the precursor of HP‐2, regulates epithelial barrier integrity. We investigated the
Kun‐Woo Park   +4 more
wiley   +1 more source

OMALIZUMAB FOR CHILDREN WITH BRONCHIAL ASTHMA: INDICATIONS TO APPLICATION

open access: yesПедиатрическая фармакология, 2007
Antibodies to IgE are a totally new class of medications currently used to enhance the supervision over severe persistent atopic bronchial asthma. Omalizumab is the most well studied, first and only medication of this group, which is recommended for the ...
T.V. Kulichenko
doaj   +2 more sources

Sex, Allergic Diseases and Omalizumab [PDF]

open access: gold, 2022
Maria Maddalena Sirufo   +3 more
openalex   +1 more source

Effectiveness and Safety of Omalizumab for Chronic Spontaneous Urticaria During Pregnancy: A Systematic Review

open access: yes
International Journal of Dermatology, EarlyView.
Ioannis‐Alexios Koumprentziotis   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy